Concord Biotech Share Price Today - Live Concord Biotech Stock Price NSE/BSE

COMPANY SNAPSHOT

Concord Biotech Share Price

BUY SELL

BSE Code: 543960
|
NSE Symbol: CONCORDBIO
|
ISIN: INE338H01029

1655.30

19.60 (1.20%)

Open (Rs)

1655.30
Close (Rs)

1635.70
High (Rs)

1688.80
Low (Rs)

1638.10

Face Value

1
Market Capital (Cr.)

17317.09
Daily Volume

237986
Life Time High

2664.00
Life Time Low

900.05
52 Week High

2664.00
52 Week Low

1327.05

|

Price Performance ADVANCED CHARTING >

Charting Corner

Key Ratios

	STOCK	IND.AVG.	RELATIVE TO IND.
Price/Earning TTM	53.4494	30.0100
Price/Book	10.4300	4.3400
Price/Sales TTM	14.9100	8.8800
Rev Growth (3 yrs Avg.)	19.2000	30.0000
EPS Growth (3 yrs Avg.)	28.3300	-41.5200
ROE TTM	21.8800	4.9700
Debt/Equity	0.0000	0.3200
ROC TTM	29.1300	9.7300
Dividend Yield	0.5700	0.3000
PBIDTM %	45.89	-44.55
PBTM %	41.32	-79.17
PATM %	31.08	-64.43

Market Analysis

3Yr's Sales V/S Peers

3Yr's PAT V/S Peers

3Yr's Dividend V/S Peers

Promoters holdings

Corporate Action 3Yrs

Event Calender

Compare This Stock With

COMPARING WITH

ADVANCE CHARTING FOR MORE COMPARISION

Top News

Concord Biotech gets final approval from USFDA for marketing Teriflunomide Tablets

The approval reinforces companys capability in successfully developing and commercializing a differentiated product portfolio for the U.S. market

Concord Biotech commences production of injectable at Valthera facility

This advanced facility has been designed and constructed to adhere to stringent international standards

Concord Biotech gets nod to make investment of Rs 6.10 crore in Clean Max Everglades

The Board of Directors of the company in their meeting held on March 4, 2025 has approved the same

Concord Biotech reports marginal decline in Q3 consolidated net profit

Total consolidated income of the company increased marginally by 4% at Rs 258.95 crore for Q3FY25

Concord biotech to acquire 26% stake of Clean Max from CMEESPL

This strategic investment reinforces the Companys commitment to environmental responsibility

Health Product Regulatory Authority issues EUGMP certificate to Concord Biotechs Valthera facility

In May 2024, Saudi Food and Drug Authority had successfully completed inspection of Concord Biotechs manufacturing unit II

Peers Companies

Stock	LTP(CHG%)	Intraday
Ranbaxy ..	859.80 (5.63)
Natco P ..	879.55 (2.00)
Aurobin ..	1160.00 (1.06)
Lupin	1960.00 (0.95)
Sai Lif ..	735.90 (0.90)

FAQ

What is the share price of Concord Biotech?

▶

The current share price of Concord Biotech is 1655.30

What is the face value of Concord Biotech?

▶

The face value of Concord Biotech is 1.

What is the market cap of Concord Biotech?

▶

Concord Biotech has a market cap of 17317.09.

What is the lifetime high of Concord Biotech

▶

The lifetime high of Concord Biotech is 2664.00.

What is the lifetime low of Concord Biotech?

▶

The lifetime low of Concord Biotech is 900.05.

What is the 52-week low of Concord Biotech?

▶

The 52-week low of Concord Biotech is 1327.05.

What is the 52-week high of Concord Biotech?

▶

The 52-week high of Concord Biotech is 2664.00.